Theravance Biopharma Files 8-K on Financials
Ticker: TBPH · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1583107
| Field | Detail |
|---|---|
| Company | Theravance Biopharma, Inc. (TBPH) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Theravance Biopharma dropped an 8-K on Feb 26th covering financials. Check it out.
AI Summary
Theravance Biopharma, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in the Cayman Islands and its principal executive offices are located in South San Francisco, California.
Why It Matters
This filing provides an update on Theravance Biopharma's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Theravance Biopharma, Inc. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event Reported
- Cayman Islands (jurisdiction) — State or Other Jurisdiction of Incorporation
- 901 Gateway Boulevard South San Francisco , CA 94080 (address) — Addresses of principal executive offices
- ( 650 ) 808-6000 (phone_number) — Telephone number of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Theravance Biopharma, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 26, 2025.
Where is Theravance Biopharma, Inc. incorporated?
Theravance Biopharma, Inc. is incorporated in the Cayman Islands.
What is the principal business address for Theravance Biopharma, Inc.?
The principal business address is C/O Theravance Biopharma US, LLC, 901 Gateway Boulevard South San Francisco, CA 94080.
What is the telephone number listed for Theravance Biopharma, Inc.'s principal executive offices?
The telephone number listed is (650) 808-6000.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding Theravance Biopharma, Inc. (TBPH).